Warren – October 31, 2026 -- PTC Therapeutics (NASDAQ: PTCT) granted stock options on 9,620 shares and 11,535 restricted stock units to 13 new employees, with the options struck at $63.02 per share.
Compensation Committee approved the grants on Oct. 28 under Nasdaq's inducement exception
The awards were made under the Nasdaq inducement grant exception, Listing Rule 5635(c)(4). PTC describes them as material to each employee's decision to accept employment. The options are non-statutory.
Option exercise price is set at the $63.02 closing price on the grant date
The exercise price matches PTC's closing share price on Oct. 28, 2026. Each option has a 10-year term and vests over four years. A 25% tranche vests on the first anniversary of the employee's hire date. After that, 6.25% of the original share count vests at the end of each three-month period until fully vested. Vesting depends on continued service.
RSUs vest in four equal annual installments
Each RSU represents the right to receive one share of common stock. The units vest over four years, with 25% of the original number vesting on each annual anniversary of the employee's hire date. Continued service is required through each vesting date.